| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |